Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis

Thorax

Volumn 53, Issue 12, 1998, Pages 1018-1021

  Hull, Jeremy ^a   Thomson, Anne H ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Disease severity; Genetic modifiers

Indexed keywords

GLUTATHIONE TRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CYSTIC FIBROSIS; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK; SCHOOL CHILD; THORAX RADIOGRAPHY; TISSUE INJURY;

EID: 0031678410     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.12.1018     Document Type: Article

References (33)

1. Kubesch P, Dörk T, Wulbrand U, et al. Genetic determinants of airways colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet 1993;341:189-93.
2. Lester LA, Kraut J, Lloyd-Still J, et al. Delta-F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population. Pediatrics 1994;93:114-8.
3. Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996;12:280-7.
4. Brown RK, Wyatt H, Price JF, et al. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334-9.
5. Hull J, Vervaart P, Grimwood K, et al. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997;52:557-60.
6. O'Connor C M, Gaffney K, Keane J, et al. Alpha 1-proteinase inhibitor elastase activity and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993;148: 1665-70.
7. Bonfield TL, Pansuka JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-8.
8. Greally P, Hussein MJ, Cook AJ, et al. Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child 1993;68:389-92.
9. Wilson AG, di Giovine FS, Blakemore AIF, et al. Single base polymorphism in the human tumour necrosis factor alpha (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
10. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391-9.
11. Wilson AG, Symons JA, McDowell TL, et al. Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994;33(Suppl 1):89.
12. McGuire W, Hill AVS, Allsopp CE, et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
13. Messer G, Kick G, Ranki A, et al. Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 1994;189(Suppl 1):135-7.
14. Huang S-L, Su C-H, Chang S-C. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997;156:1436-9.
15. Wilkinson J, Clapper ML. Detoxification enzymes and chemoprevention. Proc Soc Exp Biol Med 1997;216:192-200.
16. Groppi A, Coutelle C, Fleury B, et al. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum Genet 1991;87:628-30.
17. Seidegard J, Vorachek WR, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene are due to a gene deletion. Proc Nat Acad Sci USA 1988;85:7293-7.
18. Heagerty AHM, Fitzgerald D, Smith A, et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 1994;343:266-7.
19. Strange RC, Matharoo B, Faulder GC, et al. The human glutathione S-transferases: a case control study of the incidence of the GSTM1 0 phenotype in patients with adenocarcinoma. Carcinogensis 1991;12:25-8.
20. Harrison DJ, Cantlay AM, Rae F, et al. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;16: 356-60.
21. Baranova H, Perriot J, Albuisson E, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 1997;99:822-6.
22. Baranov VS, Ivashenko T, Bakay B, et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and other multifactorial diseases. Hum Genet 1996;97:517-20.
23. Chrispin AR, Norman AP. The systemic evaluation of the chest radiograph with cystic fibrosis. Pediatr Radiol 1974;2: 101-5.
24. Shwachman H, Kulczycki LL. Long term study of one hundred and five patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
25. Brockmöller J, Kerb R, Drakoulis N, et al. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case control study. Cancer Res 1994;54:4103-11.
26. Zielenski J, Tsui L-C. Cystic fibrosis: genotype and phenotypic variations. Annu Rev Genet 1995;29:777-807
27. Johansen HK, Nir M, Hoiby N, et al. Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet 1991;337:631-4.
28. 508). N Engl J Med 1990;323: 1517-22.
29. 2-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr Pulmonol 1994;18:3-7.
30. Fernandez-Real JM, Gutierrez C, Ricart W, et al. The TNF-alpha gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997;46:1468-72.
31. Deng GY, Maclaren NK, Huang HS, et al. No primary association between the -308 polymorphism in the tumor necrosis alpha promoter region and insulin-dependent diabetes mellitus. Hum Immunol 1996,45:137-42.
32. Rudwaleit M, Tikly M, Khamashta M, et al. Interethnic differences in the association of tumor necrosis factor polymorphisms with systemic lupus erythematosus. J Rheumatol 1996;23:1725-8.
33. Portal BC, Richard M-J, Faure R, et al. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995;61:843-7.